Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The responsibility of the folate deficiency in some neuropsychiatric disorders is recent knowledge. The role of the folate on the nervous system is not yet well definite, but the action on the metabolism of the amino-acids, on the purine and the pyrimidine synthesis and on the metabolism of the catecholamins are certainly essential. The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes,
insomnia
, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage),
restless legs syndrome
. Clinically the diagnosis may be difficult with sub acute combined degenration secondary to the pernicious anaemia, and the dosage of the folate (in serum, in red-cells and in cerebrospinal fluid) is necessary. The congenital defects in the uptake or utilization of the folate are associated with neuropsychiatric disturbances. The treatment is easy and safe if the vitamin B12 deficiency is eliminated and if employed with caution in epileptic patients because folate can induced seizures.
...
PMID:[Folate and the nervous system (author's transl)]. 22 16
This clinical study of 62 patients with
restless legs syndrome
and associated anxious-depressed and other clinical states seems to indicate that caffeine is the major etiological factor in the causation of the
restless legs syndrome
. Anxiety, while modifying the subjective experience of the dysphoric sensation of
restless legs
, is not a causative factor. Caffeine is responsible for the increased nervous system arousal as well as for the direct peripheral contractile effect on the striated muscle. This arousal is often reflected psychologically in anxiety and sometimes depressive manifestations,
insomnia
, heightened proprioceptive awareness and physiologically in the toxic sensory experience of
restless legs
associated with increased neuromuscular reactivity which may include myoclonus and myokomia.
...
PMID:Restless legs, anxiety and caffeinism. 69 85
The
restless legs syndrome
is restlessness of the extremities, particularly the legs. It occurs mainly during the hours before going to sleep or during the sleep and it frequently causes a refractory
insomnia
. The patients feel a typical, almost indefinable, particuliar crawling sensation reminiscent of the movement of worms. The intensity of this feeling may vary from time to time. From literature and our experience we concluded that this syndrome is not a disease of itself but an early symptom of an intoxication or auto-intoxication process.
...
PMID:[Restless legs syndrome]. 69 94
The elderly have more organic sleep problems disturbing sleep and contributing to
insomnia
than younger individuals. The most common disorders afflicting the elderly are obstructive sleep apnea,
restless legs syndrome
, and nocturnal myoclonus. Poor sleep habits often aggravate or contribute to the ongoing difficulty with sleeping. In the depressed elderly, characteristic EEG changes occur that may help distinguish major depression from pseudodementia; however, it should be considered that pseudodementia may be a harbinger of primary dementia. A careful sleep history and often evaluation by polysomnography are central to the management of sleep problems in the elderly. In conjunction with treatment of any underlying organic sleep disorders, brief administration of short-acting benzodiazepine sedatives for sleep onset
insomnia
or rapid-acting intermediate half-life benzodiazepines for sleep maintenance
insomnia
can be quite helpful in the elderly, especially if behavioral techniques also are employed. Elimination of medications, alcohol, and caffeine, which disturb sleep, is also an important part of the treatment approach.
...
PMID:Sleep disorders in geriatric patients. 160 Apr 90
Forty-eight chronic hemodialysis (HD) patients (pts) completed questionnaires that used linear analogue scales (LAS), yes/no responses, and demographic data collection to characterize sleep disorders. Twenty-five pts (52%) reported problems sleeping. These pts graded sleep problems significantly higher than those without sleep problems (6.5 +/- 3 vs. 1.8 +/- 2, p less than 0.001 by LAS). Those with sleep disorders were more likely to smoke cigarettes (13/25 vs. 6/23, p less than 0.05) and have bone pain (14/25 vs. 6/23, p less than 0.05). No differences among pts with and without sleep problems were seen in age, gender, time on dialysis, caffeine intake, pruritus, feelings of sadness, worry, or anxiety, or Kt/V values (1.5 +/- 0.2 vs. 1.4 +/- 0.2, p less than 0.13).
Restless legs
(84%), onset
insomnia
(76%), and nighttime (76%) and early A.M. waking (72%) characterized the sleep disorders; symptoms suggesting nocturnal myoclonus were less common (20%). We conclude that sleep disorders are common in HD pts and may be exacerbated by tobacco use, bone pain, and
restless legs
. Kt/V does not correlate with sleep disorders. Further examination of this problem, including formal sleep studies, is needed.
...
PMID:Characterizing sleep disorders in chronic hemodialysis patients. 175 Dec 35
In 1984-85, 1855 elderly residents of an urban community responded to a comprehensive baseline interview that included questions regarding an extensive set of sleep characteristics and problems. During the subsequent 3 1/2 years of follow-up, 16.7% of the respondents died and 3.5% were placed in nursing homes. The predictive significance of each sleep characteristic for mortality and for nursing home placement was determined separately for males and females, using Cox proportional hazards models. Selected demographic and psychosocial variables were also entered into the models. Age, problems with activities of daily living (ADL), self-assessed health, income, cognitive impairment, depression and whether respondents were living alone were controlled for statistically. Of the many variables analyzed, in males
insomnia
was the strongest predictor of both mortality and nursing home placement. For mortality, the relative hazard associated with
insomnia
exceeded the hazards associated with age, ADL problems, fair-poor health and low income. For nursing home placement, the hazard associated with
insomnia
exceeded that associated with cognitive impairment. The relationships of
insomnia
to mortality and nursing home placement were U-shaped, with a worse outcome if
insomnia
complaints over the preceding 2 weeks were either prominent (numerous or frequent) or absent. For females,
insomnia
was a borderline predictor of mortality and did not predict nursing home placement at all. Symptoms of the
restless legs syndrome
predicted mortality for females in some Cox regression models. Reported sleep duration, symptoms of sleep apnea and frequent use of hypnotic drugs did not predict mortality or nursing home placement in either sex.
...
PMID:Sleep problems in the community elderly as predictors of death and nursing home placement. 235 10
The
restless legs syndrome
(RLS) is characterized by unusual sensations in the lower legs which are difficult to describe. These sensations are experienced in the muscles and bones. They always occur at rest, most frequently at night, and disappear normally on movement. The etiology and pathogenesis are still unknown. The incidence is stated to be 5%. RLS is the fourth most frequent cause of
insomnia
. Treatment has been empirical. In recent single controlled investigations clonazepam (Rivotril), carbamazepine (Tegretol) and levodopa plus benserazide (Madopar) have all proved to be superior to a placebo and these drugs are, therefore, recommended. Local treatment should, however, be tried initially in all patients.
...
PMID:[The restless leg syndrome]. 292 37
Patients with
restless legs syndrome
often have difficulty describing their symptoms. Three features characterize the classic syndrome: an unusual, almost indescribable sensation in the lower extremities; an irresistible urge to move the legs, and the exclusive occurrence of the symptoms at rest, with their relief by movement.
Restless legs syndrome
may cause severe
insomnia
. Variants of the syndrome, as well as numerous associated conditions, have been described. The etiology is unknown. Clonazepam and carbamazepine are reported to be effective in treating this syndrome.
...
PMID:Restless legs syndrome. 351 May 20
Sixteen patients with symptoms of
restless legs syndrome
and resulting
insomnia
are included in this study. They were nine women and seven men with a mean age of 50.8 years and with a mean duration of symptoms of 6.3 years. The purpose of the study is to determine the drugs that are useful for the treatment of
restless legs syndrome
. In 13 patients L-Dopa plus benserazide, in two patients bromocriptine, and in the remaining one patient piribedil were used orally at night approximately 1 h before bedtime. Compared with placebo these dopaminergic drugs decreased the times of waking up and staying awake periods at a statistically significant level (p changed between 0.025 and 0.01, t test). In this susceptibility of CNS there is dysfunction of the dopamine system triggered by sleep, and resting and dopaminergic potentiation by drugs affect the symptoms.
...
PMID:Restless legs syndrome treatment with dopaminergic drugs. 354 61
Restless leg syndrome
is a frequently misdiagnosed and often misunderstood condition contributing to a complaint of
insomnia
in geriatric patients. Various pharmacologic agents used to treat the condition are often ineffective and have not consistently provided relief for the majority of patients with this condition. Our recent experience with Xanax suggests its possible effectiveness in controlling symptoms of the restless leg syndrome. Further, more controlled double blind studies--especially comparing other benzodiazepines at appropriate dosages--are called for.
...
PMID:Possible efficacy of alprazolam in restless leg syndrome. 355 97
1
2
3
4
5
6
7
8
9
10
Next >>